The results from numerous studies have supported a relationship between plasma adiponectin levels and risk for CRC [12, 10, 13], and variants of the adiponectin gene (APN) have been shown to be associated with CRC risk [14, 15]. The gene discussed is ADIPOQ; the disease is colorectal carcinoma.